PHS
MSFT icon

PFM Health Sciences’s Microsoft MSFT Stock Holding History

PFM Health Sciences’s Portfolio MSFT Stock Details MSFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-95,177
Closed -$20M – 95
2020
Q3 		$20M Hold
95,177
– – 0.93% 42
2020
Q2 		$19.4M Hold
95,177
– – 1% 37
2020
Q1 		$15M Buy
95,177
+23,810
+33% +$3.92M 1.23% 32
2019
Q4 		$11.3M Sell
71,367
-179,236
-72% -$26.3M 0.54% 46
2019
Q3 		$34.8M Sell
250,603
-151,976
-38% -$20.9M 1.03% 37
2019
Q2 		$53.9M Buy
402,579
+106,279
+36% +$13.5M 1.02% 34
2019
Q1 		$34.9M Sell
296,300
-397,974
-57% -$43.4M 0.77% 45
2018
Q4 		$70.5M Buy
694,274
+346,164
+99% +$37.1M 1.87% 19
2018
Q3 		$39.8M Buy
348,110
+338,972
+3,709% +$36.7M 0.58% 64
2018
Q2 		$901K Sell
9,138
-1,047,741
-99% -$102M 0.01% 114
2018
Q1 		$96.5M Buy
1,056,879
+739,938
+233% +$67.7M 1.96% 14
2017
Q4 		$27.1M Sell
316,941
-729,926
-70% -$59.9M 0.64% 54
2017
Q3 		$78M Sell
1,046,867
-128,436
-11% -$9.38M 1.53% 23
2017
Q2 		$81M Buy
1,175,303
+845,099
+256% +$58M 2.18% 13
2017
Q1 		$21.7M Buy
+330,204
New +$21.2M 0.54% 62
2016
Q3 		– Sell
-1,026,566
Closed -$52.5M – 100
2016
Q2 		$52.5M Sell
1,026,566
-340,537
-25% -$17.7M 1.58% 25
2016
Q1 		$75.5M Buy
1,367,103
+874,960
+178% +$45.9M 2.33% 17
2015
Q4 		$27.3M Buy
+492,143
New +$25.9M 0.83% 39
2015
Q1 		– Sell
-5,636,799
Closed -$262M – 95
2014
Q4 		$262M Buy
5,636,799
+2,705,590
+92% +$127M 6.11% 2
2014
Q3 		$136M Buy
2,931,209
+1,221,856
+71% +$54.5M 3.13% 11
2014
Q2 		$71.3M Buy
+1,709,353
New +$69.2M 1.43% 27

Other funds holding MSFT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFM Health Sciences's MSFT Position: Q4 2020 in Review

PFM Health Sciences sold out of Microsoft (MSFT) in Q4 2020, closing a stake of 95,177 shares — an estimated $20M sold.

PFM Health Sciences first reported a position in MSFT in Q2 2014 and held it in 21 quarters. The position peaked at $262M in Q4 2014. 3,973 funds tracked by Wall St. Rank hold MSFT as of Q4 2020.

  • PFM Health Sciences reported no remaining Microsoft position as of Q4 2020 after selling out during the quarter.
  • PFM Health Sciences sold 95,177 Microsoft shares in Q4 2020, an estimated $20M.
  • PFM Health Sciences first reported a position in Microsoft in Q2 2014 and held it in 21 quarters.
  • PFM Health Sciences's Microsoft position peaked at $262M in Q4 2014.
  • 3,973 funds tracked by Wall St. Rank held Microsoft as of Q4 2020.

Based on PFM Health Sciences's 13F filing for Q4 2020, filed 16 Feb 2021.